It’s important…Register for Cancer Research and Oncology 2018.



It seems like everyone knows someone with cancer. It is one of those diseases that touches millions of lives. Because of this, the cancer research and clinical communities work tirelessly to learn more about the many different types and mechanisms of cancer as well as to develop new treatments to beat the disease in a safe and efficacious manner.

LabRoots’ 6th Annual Cancer Research & Oncology Virtual Event will take place October 10-11, 2018 and aims to bring together the cancer community. Through collaborations, sharing new findings, and connecting with colleagues, the event works to further advance our knowledge of how cancer takes over our bodies and what types of new therapies can help eliminate it. The free, two-day online event will bring research professionals, scientists, and clinicians from around the world to learn and discuss recent advances in cancer research.

Cancer Research & Oncology 2018 will address a range of topics including:

  • Cancer vaccines
  • Immunotherapy and other therapeutics
  • Analysis of tumor growth
  • Immunogenic cell death in cancer: the quantity/quality conundrum”
  • Biomarker discovery from big pharmacogenomic data
  • Cancer epigenetics
  • Genetic markers / Biomarkers
  • Organ-specific cancers
  • ENT / Thyroid
  • Breast
  • Colon
  • Lung
  • Multiple Myelomas
  • Neuro-oncology

Cancer Research and Oncology 2018 Speakers:

Karin Rodland, PhD – Director and Professor, Biological Sciences Division, Pacific Northwest National Laboratory

Krastan Blagoev – Program Director, National Science Foundation

Jason De Melo, PhD – Post-Doctoral Fellow, Princess Margaret Cancer Research, University Health Network

Peter Dirks, MD, PhD – Senior Scientist and Neurosurgeon, Garron Family Chair in Childhood Cancer Research, The Hospital for Sick Children, Professor of Surgery and Molecular Genetics, University of Toronto

Lorenzo Galluzzi, PhD – Assistant Professor, Weill Cornell Medical College/New York Presbyterian

Jerome Galon, PhD – Research Director, French Institute of Health and Medical Research

Benjamin Haibe-Kains, PhD – Assistant Professor, Princess Margaret Cancer Center, University of Toronto

Keith Knutson, PhD – Professor, Mayo Clinic

Costas A. Lyssiotis, PhD – Assistant Professor, Department of Molecular and Integrative Physiology, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Rogel Cancer Center, University of Michigan

Nicholas McGranahan, PhD – Senior Research Associate, Cancer Genome Evolution Research Group, University College London

Jonathan Shaffer, PhD – Associate Director, NGS Assay Technologies, QIAGEN

Khyati Shah, PhD – Post Doctoral Research Scholar at University of California, San Francisco

Paul Sondel, MD, PhD – Professor of Pediatrics, Department of Human Oncology & Genetics, University of Wisconsin-Madison

Marina Walther-Antonio, PhD – Associate Consultant, Department of Surgery & Department of Obstetrics & Gynecology, Assistant Professor, Microbiome Program, Center for Individualized Medicine, Mayo Clinic

Jennifer Wargo, MD – Associate Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center

Kevin Williams, PhD – Associate Professor, Biomanufacturing Research Institute and Technology Enterprise, NC Central University

Lori Wirth, MD – Medical Director, Head and Neck Oncology, Massachusetts General Hospital

In addition to providing a global setting with increased reach for the global cancer community, you can participate in exactly those parts which you are interested in with a high degree of interaction through live-streaming video and chat sessions. Interested in sharing your research? If you’re working on some remarkable breakthroughs and would like to submit a speaker or panel for consideration, please contact us! Instead, if you would like to have your poster included in the virtual poster session, you can do that, too.

Use #LRcancer to follow the conversation!

No Comments

Sorry, the comment form is closed at this time.